China Evolution Equity Fund_CEE_F1228-052
0000313212falseN-CSRST. ROWE PRICE INTERNATIONAL FUNDS, INC.N-1A2025-04-300000313212trp:C000215155Member2024-11-012025-04-3000003132122024-11-012025-04-300000313212trp:C000215155Member2025-04-300000313212trp:C000215155Membertrp:IndustrialsBusinessServicesSectorMember2025-04-300000313212trp:C000215155Memberoef:ConsumerDiscretionarySectorMember2025-04-300000313212trp:C000215155Memberoef:InformationTechnologySectorMember2025-04-300000313212trp:C000215155Memberus-gaap:RealEstateSectorMember2025-04-300000313212trp:C000215155Membertrp:CommunicationServicesSectorMember2025-04-300000313212trp:C000215155Memberoef:ConsumerStaplesSectorMember2025-04-300000313212trp:C000215155Memberoef:MaterialsSectorMember2025-04-300000313212trp:C000215155Memberus-gaap:HealthcareSectorMember2025-04-300000313212trp:C000215155Memberus-gaap:EnergySectorMember2025-04-300000313212trp:C000215155Membertrp:OtherHoldingsGroupingSectorMember2025-04-300000313212trp:C000215155Membertrp:ChinaResourcesMixcLifestyleServicesCTIMember2025-04-300000313212trp:C000215155Membertrp:WillSemiconductorShanghaiCTIMember2025-04-300000313212trp:C000215155Membertrp:GumingHoldingsCTIMember2025-04-300000313212trp:C000215155Membertrp:CRRCCTIMember2025-04-300000313212trp:C000215155Membertrp:YankershopFoodCTIMember2025-04-300000313212trp:C000215155Membertrp:TencentMusicEntertainmentGroupCTIMember2025-04-300000313212trp:C000215155Membertrp:ChinaTowerCTIMember2025-04-300000313212trp:C000215155Membertrp:HongfaTechnologyCTIMember2025-04-300000313212trp:C000215155Membertrp:NinebotCTIMember2025-04-300000313212trp:C000215155Membertrp:KEHoldingsCTIMember2025-04-300000313212trp:C000215156Member2024-11-012025-04-300000313212trp:C000215156Member2025-04-300000313212trp:C000215156Membertrp:IndustrialsBusinessServicesSectorMember2025-04-300000313212trp:C000215156Memberoef:ConsumerDiscretionarySectorMember2025-04-300000313212trp:C000215156Memberoef:InformationTechnologySectorMember2025-04-300000313212trp:C000215156Memberus-gaap:RealEstateSectorMember2025-04-300000313212trp:C000215156Membertrp:CommunicationServicesSectorMember2025-04-300000313212trp:C000215156Memberoef:ConsumerStaplesSectorMember2025-04-300000313212trp:C000215156Memberoef:MaterialsSectorMember2025-04-300000313212trp:C000215156Memberus-gaap:HealthcareSectorMember2025-04-300000313212trp:C000215156Memberus-gaap:EnergySectorMember2025-04-300000313212trp:C000215156Membertrp:OtherHoldingsGroupingSectorMember2025-04-300000313212trp:C000215156Membertrp:ChinaResourcesMixcLifestyleServicesCTIMember2025-04-300000313212trp:C000215156Membertrp:WillSemiconductorShanghaiCTIMember2025-04-300000313212trp:C000215156Membertrp:GumingHoldingsCTIMember2025-04-300000313212trp:C000215156Membertrp:CRRCCTIMember2025-04-300000313212trp:C000215156Membertrp:YankershopFoodCTIMember2025-04-300000313212trp:C000215156Membertrp:TencentMusicEntertainmentGroupCTIMember2025-04-300000313212trp:C000215156Membertrp:ChinaTowerCTIMember2025-04-300000313212trp:C000215156Membertrp:HongfaTechnologyCTIMember2025-04-300000313212trp:C000215156Membertrp:NinebotCTIMember2025-04-300000313212trp:C000215156Membertrp:KEHoldingsCTIMember2025-04-30iso4217:USDxbrli:sharesiso4217:USDxbrli:sharesxbrli:pureutr:Dtrp:Holding

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED

MANAGEMENT INVESTMENT COMPANIES

Investment Company Act File Number: 811-02958

T. Rowe Price International Funds, Inc.

 

(Exact name of registrant as specified in charter)

1307 Point Street, Baltimore, MD 21231

 

(Address of principal executive offices)

David Oestreicher

1307 Point Street, Baltimore, MD 21231

 

(Name and address of agent for service)

Registrant’s telephone number, including area code: (410) 345-2000

Date of fiscal year end: October 31

Date of reporting period: April 30, 2025

Item 1. Reports to Shareholders

(a) EReport pursuant to Rule 30e-1

Image

Semi-Annual Shareholder Report

April 30, 2025

China Evolution Equity Fund

Investor Class (TCELX)

This semi-annual shareholder report contains important information about China Evolution Equity Fund (the "fund") for the period of November 1, 2024 to April 30, 2025. You can find the fund’s prospectus, financial information on Form N‑CSR (which includes required tax information for dividends), holdings, proxy voting information, and other information atwww.troweprice.com/prospectus. You can also request this information without charge by contacting T. Rowe Price at 1‑800‑638‑5660 or info@troweprice.com or contacting your intermediary. 

What were the fund costs for the last six months? (based on a hypothetical $10,000 investment)

 
Costs of a $10,000 investment
Costs paid as a percentage of a $10,000 investment
China Evolution Equity Fund - Investor Class
$70
1.40%

What are some fund statistics?

Fund Statistics

Total Net Assets (000s)
$41,660
Number of Portfolio Holdings
53
Portfolio Turnover Rate
59.9%

What did the fund invest in?

Sector Allocation (as a % of Net Assets)

Industrials & Business Services
26.3%
Consumer Discretionary
16.6
Information Technology
16.1
Real Estate
10.3
Communication Services
8.0
Consumer Staples
6.4
Materials
5.9
Health Care
4.4
Energy
2.4
Other
3.6

Top Ten Holdings (as a % of Net Assets)

China Resources Mixc Lifestyle Services
4.8%
Will Semiconductor Shanghai
3.3
Guming Holdings
3.2
CRRC
3.1
Yankershop Food
3.0
Tencent Music Entertainment Group
2.8
China Tower
2.8
Hongfa Technology
2.7
Ninebot
2.5
KE Holdings
2.5

If you invest directly with T. Rowe Price, you can elect to receive future shareholder reports or other important documents through electronic delivery by enrolling at www.troweprice.com/paperless. If you invest through a financial intermediary such as an investment advisor, a bank, retirement plan sponsor or a brokerage firm, please contact that organization and ask if it can provide electronic delivery.

Visit www.troweprice.com/en/us/market-data-disclosures for additional legal notices & disclaimers.

202505-4461501

F1228-053 6/25

China Evolution Equity Fund 

Investor Class (TCELX)

T. Rowe Price Investment Services, Inc.

1307 Point Street

Baltimore, Maryland 21231

Image
Image

Semi-Annual Shareholder Report

April 30, 2025

China Evolution Equity Fund

I Class (TRCLX)

This semi-annual shareholder report contains important information about China Evolution Equity Fund (the "fund") for the period of November 1, 2024 to April 30, 2025. You can find the fund’s prospectus, financial information on Form N‑CSR (which includes required tax information for dividends), holdings, proxy voting information, and other information atwww.troweprice.com/prospectus. You can also request this information without charge by contacting T. Rowe Price at 1‑800‑638‑5660 or info@troweprice.com or contacting your intermediary. 

What were the fund costs for the last six months? (based on a hypothetical $10,000 investment)

 
Costs of a $10,000 investment
Costs paid as a percentage of a $10,000 investment
China Evolution Equity Fund - I Class
$52
1.04%

What are some fund statistics?

Fund Statistics

Total Net Assets (000s)
$41,660
Number of Portfolio Holdings
53
Portfolio Turnover Rate
59.9%

What did the fund invest in?

Sector Allocation (as a % of Net Assets)

Industrials & Business Services
26.3%
Consumer Discretionary
16.6
Information Technology
16.1
Real Estate
10.3
Communication Services
8.0
Consumer Staples
6.4
Materials
5.9
Health Care
4.4
Energy
2.4
Other
3.6

Top Ten Holdings (as a % of Net Assets)

China Resources Mixc Lifestyle Services
4.8%
Will Semiconductor Shanghai
3.3
Guming Holdings
3.2
CRRC
3.1
Yankershop Food
3.0
Tencent Music Entertainment Group
2.8
China Tower
2.8
Hongfa Technology
2.7
Ninebot
2.5
KE Holdings
2.5

If you invest directly with T. Rowe Price, you can elect to receive future shareholder reports or other important documents through electronic delivery by enrolling at www.troweprice.com/paperless. If you invest through a financial intermediary such as an investment advisor, a bank, retirement plan sponsor or a brokerage firm, please contact that organization and ask if it can provide electronic delivery.

Visit www.troweprice.com/en/us/market-data-disclosures for additional legal notices & disclaimers.

202505-4461501

F1229-053 6/25

China Evolution Equity Fund 

I Class (TRCLX)

T. Rowe Price Investment Services, Inc.

1307 Point Street

Baltimore, Maryland 21231

Image

Item 1. (b) Notice pursuant to Rule 30e-3.

Not applicable.

Item 2. Code of Ethics.

A code of ethics, as defined in Item 2 of Form N-CSR, applicable to its principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions is filed as an exhibit to the registrant’s annual Form N-CSR. No substantive amendments were approved or waivers were granted to this code of ethics during the registrant’s most recent fiscal half-year.

Item 3. Audit Committee Financial Expert.

Disclosure required in registrant’s annual Form N-CSR.

Item 4. Principal Accountant Fees and Services.

Disclosure required in registrant’s annual Form N-CSR.

Item 5. Audit Committee of Listed Registrants.

Not applicable.

Item 6. Investments.

(a) Not applicable. The complete schedule of investments is included in Item 7 of this Form N-CSR.

(b) Not applicable.

Item 7. Financial Statements and Financial Highlights for Open-End Management Investment Companies.

(a – b) Report pursuant to Regulation S-X.

 

Financial
Highlights
Portfolio
of
Investments
Financial
Statements
and
Notes
Additional
Fund
Information
April
30,
2025
Financial
Statements
and
Other
Information
For
more
insights
from
T.
Rowe
Price
investment
professionals,
go
to
troweprice.com
.
T.
ROWE
PRICE
TCELX
China
Evolution
Equity
Fund
TRCLX
China
Evolution
Equity
Fund–
.
I Class
T.
ROWE
PRICE
China
Evolution
Equity
Fund
(Unaudited)
Financial
Highlights
2
For
a
share
outstanding
throughout
each
period
Investor
Class
6
Months
.
Ended
4/30/25
..
Year
..
..
Ended
.
12/10/19
(1)
Through
10/31/20
10/31/24
10/31/23
10/31/22
10/31/21
NET
ASSET
VALUE
Beginning
of
period
$
11
.15‌
$
10
.00‌
$
9
.67‌
$
17
.40‌
$
14
.95‌
$
10
.00‌
Investment
activities
Net
investment
income
(loss)
(2)(3)
(
0
.04‌
)
0
.18‌
0
.04‌
(
0
.01‌
)
(
0
.03‌
)
(
—‌
)
(4)
Net
realized
and
unrealized
gain/
loss
0
.20‌
1
.19‌
0
.45‌
(
6
.65‌
)
2
.73‌
4
.95‌
Total
from
investment
activities
0
.16‌
1
.37‌
0
.49‌
(
6
.66‌
)
2
.70‌
4
.95‌
Distributions
Net
investment
income
(
0
.15‌
)
(
0
.22‌
)
(
0
.16‌
)
—‌
—‌
—‌
Net
realized
gain
—‌
—‌
—‌
(
1
.07‌
)
(
0
.25‌
)
—‌
Total
distributions
(
0
.15‌
)
(
0
.22‌
)
(
0
.16‌
)
(
1
.07‌
)
(
0
.25‌
)
—‌
NET
ASSET
VALUE
End
of
period
$
11
.16‌
$
11
.15‌
$
10
.00‌
$
9
.67‌
$
17
.40‌
$
14
.95‌
T.
ROWE
PRICE
China
Evolution
Equity
Fund
(Unaudited)
Financial
Highlights
3
For
a
share
outstanding
throughout
each
period
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Investor
Class
6
Months
.
Ended
4/30/25
..
Year
..
..
Ended
.
12/10/19
(1)
Through
10/31/20
10/31/24
10/31/23
10/31/22
10/31/21
Ratios/Supplemental
Data
Total
return
(3)(5)
1
.55‌
%
14
.13‌
%
4
.78‌
%
(
40
.83‌
)
%
18
.22‌
%
49
.50‌
%
Ratios
to
average
net
assets:
(3)
Gross
expenses
before
waivers/
payments
by
Price
Associates
2
.07‌
%
(6)
2
.67‌
%
2
.17‌
%
1
.94‌
%
1
.45‌
%
2
.49‌
%
(6)
Net
expenses
after
waivers/
payments
by
Price
Associates
1
.40‌
%
(6)
1
.40‌
%
1
.40‌
%
1
.40‌
%
1
.40‌
%
1
.43‌
%
(6)
Net
investment
income
(loss)
(
0
.73‌
)
%
(6)
1
.75‌
%
0
.32‌
%
(
0
.08‌
)
%
(
0
.19‌
)
%
(
0
.03‌
)
%
(6)
Portfolio
turnover
rate
59
.9‌
%
82
.4‌
%
54
.6‌
%
62
.2‌
%
106
.6‌
%
60
.6‌
%
Net
assets,
end
of
period
(in
thousands)
$21,676
$27,219
$15,953
$17,584
$63,037
$40,838
0‌
%
0‌
%
0‌
%
0‌
%
0‌
%
0‌
%
(1)
Inception
date
(2)
Per
share
amounts
calculated
using
average
shares
outstanding
method.
(3)
Includes
the
impact
of
expense-related
arrangements
with
Price
Associates.
(4)
Amounts
round
to
less
than
$0.01
per
share.
(5)
Total
return
reflects
the
rate
that
an
investor
would
have
earned
on
an
investment
in
the
fund
during
each
period,
assuming
reinvestment
of
all
distributions,
and
payment
of
no
redemption
or
account
fees,
if
applicable.
Total
return
is
not
annualized
for
periods
less
than
one
year.
(6)
Annualized
T.
ROWE
PRICE
China
Evolution
Equity
Fund
(Unaudited)
Financial
Highlights
4
For
a
share
outstanding
throughout
each
period
I
Class
6
Months
.
Ended
4/30/25
..
Year
..
..
Ended
.
12/10/19
(1)
Through
10/31/20
10/31/24
10/31/23
10/31/22
10/31/21
NET
ASSET
VALUE
Beginning
of
period
$
10
.97‌
$
9
.84‌
$
9
.62‌
$
17
.52‌
$
15
.00‌
$
10
.00‌
Investment
activities
Net
investment
income
(loss)
(2)(3)
(
0
.02‌
)
0
.22‌
0
.12‌
0
.09‌
0
.09‌
0
.05‌
Net
realized
and
unrealized
gain/
loss
0
.21‌
1
.16‌
0
.43‌
(
6
.64‌
)
2
.68‌
4
.95‌
Total
from
investment
activities
0
.19‌
1
.38‌
0
.55‌
(
6
.55‌
)
2
.77‌
5
.00‌
Distributions
Net
investment
income
(
0
.19‌
)
(
0
.25‌
)
(
0
.33‌
)
—‌
—‌
—‌
Net
realized
gain
—‌
—‌
—‌
(
1
.35‌
)
(
0
.25‌
)
—‌
Total
distributions
(
0
.19‌
)
(
0
.25‌
)
(
0
.33‌
)
(
1
.35‌
)
(
0
.25‌
)
—‌
NET
ASSET
VALUE
End
of
period
$
10
.97‌
$
10
.97‌
$
9
.84‌
$
9
.62‌
$
17
.52‌
$
15
.00‌
T.
ROWE
PRICE
China
Evolution
Equity
Fund
(Unaudited)
Financial
Highlights
5
For
a
share
outstanding
throughout
each
period
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
I
Class
6
Months
.
Ended
4/30/25
..
Year
..
..
Ended
.
12/10/19
(1)
Through
10/31/20
10/31/24
10/31/23
10/31/22
10/31/21
Ratios/Supplemental
Data
Total
return
(3)(4)
1
.81‌
%
14
.47‌
%
5
.11‌
%
(
40
.57‌
)
%
18
.63‌
%
50
.00‌
%
Ratios
to
average
net
assets:
(3)
Gross
expenses
before
waivers/
payments
by
Price
Associates
1
.71‌
%
(5)
2
.10‌
%
1
.66‌
%
1
.53‌
%
1
.28‌
%
2
.48‌
%
(5)
Net
expenses
after
waivers/
payments
by
Price
Associates
1
.04‌
%
(5)
1
.04‌
%
1
.04‌
%
1
.04‌
%
1
.04‌
%
1
.08‌
%
(5)
Net
investment
income
(loss)
(
0
.34‌
)
%
(5)
2
.19‌
%
1
.01‌
%
0
.70‌
%
0
.47‌
%
0
.45‌
%
(5)
Portfolio
turnover
rate
59
.9‌
%
82
.4‌
%
54
.6‌
%
62
.2‌
%
106
.6‌
%
60
.6‌
%
Net
assets,
end
of
period
(in
thousands)
$19,984
$21,624
$20,189
$30,679
$22,749
$2,912
0‌
%
0‌
%
0‌
%
0‌
%
0‌
%
0‌
%
(1)
Inception
date
(2)
Per
share
amounts
calculated
using
average
shares
outstanding
method.
(3)
Includes
the
impact
of
expense-related
arrangements
with
Price
Associates.
(4)
Total
return
reflects
the
rate
that
an
investor
would
have
earned
on
an
investment
in
the
fund
during
each
period,
assuming
reinvestment
of
all
distributions,
and
payment
of
no
redemption
or
account
fees,
if
applicable.
Total
return
is
not
annualized
for
periods
less
than
one
year.
(5)
Annualized
T.
ROWE
PRICE
China
Evolution
Equity
Fund
April
30,
2025
(Unaudited)
6
Portfolio
of
Investments
‡
Shares
$
Value
(
Cost
and
value
in
$000s)
‡
CHINA 89.3%
Common
Stocks 50.3% 
ATRenew,
ADR
(USD) (1)
57,288‌
142‌
BOC
Aviation
(HKD) 
94,300‌
707‌
Bosideng
International
Holdings
(HKD) 
1,734,000‌
897‌
C&D
International
Investment
Group
(HKD) 
264,000‌
552‌
China
Mengniu
Dairy
(HKD) 
272,000‌
677‌
China
Resources
Beer
Holdings
(HKD) 
211,000‌
742‌
China
Resources
Land
(HKD) 
209,000‌
703‌
China
Resources
Mixc
Lifestyle
Services
(HKD) 
416,830‌
1,997‌
China
Tower,
Class
H
(HKD) 
800,900‌
1,160‌
CMOC
Group,
Class
H
(HKD) 
1,059,000‌
831‌
CRRC,
Class
H
(HKD) 
2,086,000‌
1,287‌
H
World
Group
(HKD) 
288,100‌
1,011‌
Innovent
Biologics
(HKD) (1)
102,000‌
706‌
Kanzhun,
ADR
(USD) (1)
65,554‌
1,003‌
KE
Holdings,
ADR
(USD) 
50,995‌
1,035‌
Kingboard
Laminates
Holdings
(HKD) (2)
744,000‌
777‌
Ninebot,
CDR (3)
120,009‌
1,038‌
Shandong
Weigao
Group
Medical
Polymer,
Class
H
(HKD) 
1,313,600‌
967‌
Shanghai
Conant
Optical,
Class
H
(HKD) 
55,000‌
169‌
Shenzhou
International
Group
Holdings
(HKD) 
99,800‌
692‌
Sunny
Optical
Technology
Group
(HKD) 
70,300‌
592‌
Tencent
Music
Entertainment
Group,
ADR
(USD) 
87,273‌
1,171‌
Yadea
Group
Holdings
(HKD) (2)
278,000‌
502‌
Yum
China
Holdings
(USD) 
13,578‌
588‌
ZTO
Express
Cayman
(HKD) 
53,300‌
993‌
20,939‌
Common
Stocks
-
China
A
Shares 39.0% 
Beijing
Huafeng
Test
&
Control
Technology,
A
Shares
(CNH) 
28,041‌
561‌
China
Jushi,
A
Shares
(CNH) 
404,000‌
652‌
CNOOC
Energy
Technology
&
Services,
A
Shares
(CNH) 
764,600‌
418‌
Dongguan
Yiheda
Automation,
A
Shares
(CNH) 
124,400‌
399‌
Electric
Connector
Technology,
A
Shares
(CNH) 
146,600‌
970‌
Hongfa
Technology,
A
Shares
(CNH) 
249,947‌
1,133‌
Jiangsu
Zhongtian
Technology,
A
Shares
(CNH) 
338,600‌
651‌
Loncin
Motor,
A
Shares
(CNH) 
410,400‌
704‌
Riyue
Heavy
Industry,
A
Shares
(CNH) 
437,600‌
718‌
Sany
Heavy
Industry,
A
Shares
(CNH) 
376,000‌
980‌
Shenzhen
Envicool
Technology,
A
Shares
(CNH) 
125,800‌
552‌
T.
ROWE
PRICE
China
Evolution
Equity
Fund
7
Shares
$
Value
(Cost
and
value
in
$000s)
Shenzhen
Jufei
Optoelectronics,
A
Shares
(CNH) 
597,300‌
484‌
Weichai
Power,
A
Shares
(CNH) 
341,300‌
716‌
Will
Semiconductor
Shanghai,
A
Shares
(CNH) 
75,200‌
1,367‌
Wuxi
Xinje
Electric,
A
Shares
(CNH) 
84,400‌
599‌
Xiamen
Faratronic,
A
Shares
(CNH) 
60,134‌
862‌
Xuji
Electric,
A
Shares
(CNH) 
230,600‌
675‌
Yankershop
Food,
A
Shares
(CNH) 
100,320‌
1,242‌
Yantai
Jereh
Oilfield
Services
Group,
A
Shares
(CNH) 
132,200‌
572‌
YTO
Express
Group,
A
Shares
(CNH) 
314,800‌
568‌
Yunnan
Aluminium,
A
Shares
(CNH) 
454,400‌
953‌
Zhejiang
Dingli
Machinery,
A
Shares
(CNH) 
81,100‌
486‌
16,262‌
Total
China
(Cost
$35,951)
37,201‌
HONG
KONG 4.7%
Common
Stocks 4.7% 
Guming
Holdings (1)
423,200‌
1,336‌
Techtronic
Industries 
61,500‌
619‌
Total
Hong
Kong
(Cost
$1,242)
1,955‌
TAIWAN 2.4%
Common
Stocks 2.4% 
Airtac
International
Group 
19,000‌
522‌
Elite
Material 
28,000‌
487‌
Total
Taiwan
(Cost
$990)
1,009‌
SHORT-TERM
INVESTMENTS 3.9%
Money
Market
Funds 3.9%
T.
Rowe
Price
Government
Reserve
Fund,
4.38% (4)(5)
1,638,593‌
1,639‌
Total
Short-Term
Investments
(Cost
$1,639)
1,639‌
T.
ROWE
PRICE
China
Evolution
Equity
Fund
8
Shares
$
Value
(Cost
and
value
in
$000s)
SECURITIES
LENDING
COLLATERAL 0.5%
INVESTMENTS
IN
A
POOLED
ACCOUNT
THROUGH
SECURITIES
LENDING
PROGRAM
WITH
JPMORGAN
CHASE
BANK 0.5%
Money
Market
Funds 0.5%
T.
Rowe
Price
Government
Reserve
Fund,
4.38% (4)(5)
191,600‌
192‌
Total
Investments
in
a
Pooled
Account
through
Securities
Lending
Program
with
JPMorgan
Chase
Bank
192‌
Total
Securities
Lending
Collateral
(Cost
$192)
192‌
Total
Investments
in
Securities
100.8%
of
Net
Assets
(Cost
$40,014)
$
41,996‌
‡
Country
classifications
are
generally
based
on
MSCI
categories
or
another
unaffiliated
third
party
data
provider;
Shares
are
denominated
in
the
currency
of
the
country
presented
unless
otherwise
noted.
(1)
Non-income
producing
(2)
See
Note
3
.
All
or
a
portion
of
this
security
is
on
loan
at
April
30,
2025.
(3)
See
Note
3.
China
A
shares
held
through
the
QFII
are
subject
to
certain
restrictions.
(4)
Seven-day
yield
(5)
Affiliated
Companies
ADR
American
Depositary
Receipts
CDR
China
Depositary
Receipt
CNH
Offshore
China
Renminbi
HKD
Hong
Kong
Dollar
USD
U.S.
Dollar
T.
ROWE
PRICE
China
Evolution
Equity
Fund
9
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
AFFILIATED
COMPANIES
($000s)
The
fund
may
invest
in
certain
securities
that
are
considered
affiliated
companies.
As
defined
by
the
1940
Act,
an
affiliated
company
is
one
in
which
the
fund
owns
5%
or
more
of
the
outstanding
voting
securities,
or
a
company
that
is
under
common
ownership
or
control.
The
following
securities
were
considered
affiliated
companies
for
all
or
some
portion
of
the
six
months
ended
April
30,
2025.
Net
realized
gain
(loss),
investment
income,
change
in
net
unrealized
gain/loss,
and
purchase
and
sales
cost
reflect
all
activity
for
the
period
then
ended.
Affiliate
Net
Realized
Gain
(Loss)
Change
in
Net
Unrealized
Gain/Loss
Investment
Income
T.
Rowe
Price
Government
Reserve
Fund,
4.38%
$
—‌
$
—‌
$
29‌++
Totals
$
—‌#
$
—‌
$
29‌+
Supplementary
Investment
Schedule
Affiliate
Value
10/31/24
Purchase
Cost
Sales
Cost
Value
4/30/25
T.
Rowe
Price
Government
Reserve
Fund,
4.38%
$
2,667‌
 ¤
 ¤
$
1,831‌
Total
$
1,831‌^
#
Capital
gain
distributions
from
underlying
Price
funds
represented
$0
of
the
net
realized
gain
(loss).
++
Excludes
earnings
on
securities
lending
collateral,
which
are
subject
to
rebates
and
fees
as
described
in
Note
3
.
+
Investment
income
comprised
$29
of
dividend
income
and
$0
of
interest
income.
¤
Purchase
and
sale
information
not
shown
for
cash
management
funds.
^
The
cost
basis
of
investments
in
affiliated
companies
was
$1,831.
T.
ROWE
PRICE
China
Evolution
Equity
Fund
April
30,
2025
(Unaudited)
Statement
of
Assets
and
Liabilities
10
($000s,
except
shares
and
per
share
amounts)
t
Assets
Investments
in
securities,
at
value
(cost
$40,014)
$
41,996‌
Foreign
currency
(cost
$251)
252‌
Receivable
for
shares
sold
34‌
Due
from
affiliates
14‌
Other
assets
28‌
Total
assets
42,324‌
Liabilities
Payable
for
investment
securities
purchased
212‌
Obligation
to
return
securities
lending
collateral
192‌
Investment
management
fees
payable
35‌
Payable
for
shares
redeemed
12‌
Other
liabilities
213‌
Total
liabilities
664‌
Commitments
and
Contingent
Liabilities
(note
6
)
NET
ASSETS
$
41,660‌
Net
Assets
Consist
of:
Total
distributable
earnings
(loss)
$
(23,519‌)
Paid-in
capital
applicable
to
3,764,478
shares
of
$0.01
par
value
capital
stock
outstanding;
18,000,000,000
shares
of
the
Corporation
authorized
65,179‌
NET
ASSETS
$
41,660‌
NET
ASSET
VALUE
PER
SHARE
Investor
Class
(Net
assets:
$21,676;
Shares
outstanding:
1,942,631)
$
11.16‌
I
Class
(Net
assets:
$19,984;
Shares
outstanding:
1,821,847)
$
10.97‌
T.
ROWE
PRICE
China
Evolution
Equity
Fund
(Unaudited)
Statement
of
Operations
11
($000s)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
6
Months
Ended
4/30/25
Investment
Income
(Loss)
Income
Dividend
(net
of
foreign
taxes
of
$1)
$
154‌
Securities
lending
2‌
Total
income
156‌
Expenses
Investment
management
224‌
Shareholder
servicing
Investor
Class
$
46‌
I
Class
3‌
49‌
Prospectus
and
shareholder
reports
Investor
Class
4‌
I
Class
2‌
6‌
Custody
and
accounting
103‌
Registration
20‌
Legal
and
audit
19‌
Miscellaneous
14‌
Waived
/
paid
by
Price
Associates
(
153‌
)
Total
expenses
282‌
Net
investment
loss
(
126‌
)
T.
ROWE
PRICE
China
Evolution
Equity
Fund
(Unaudited)
Statement
of
Operations
12
($000s)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
6
Months
Ended
4/30/25
Realized
and
Unrealized
Gain
/
Loss
–
Net
realized
gain
(loss)
Securities
(
1,666‌
)
Foreign
currency
transactions
(
8‌
)
Net
realized
loss
(
1,674‌
)
Change
in
net
unrealized
gain
/
loss
Securities
1,776‌
Other
assets
and
liabilities
denominated
in
foreign
currencies
2‌
Change
in
net
unrealized
gain
/
loss
1,778‌
Net
realized
and
unrealized
gain
/
loss
104‌
DECREASE
IN
NET
ASSETS
FROM
OPERATIONS
$
(
22‌
)
T.
ROWE
PRICE
China
Evolution
Equity
Fund
(Unaudited)
Statement
of
Changes
in
Net
Assets
13
($000s)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
6
Months
Ended
4/30/25
Year
Ended
10/31/24
Increase
(Decrease)
in
Net
Assets
Operations
Net
investment
income
(loss)
$
(
126‌
)
$
718‌
Net
realized
loss
(
1,674‌
)
(
1,581‌
)
Change
in
net
unrealized
gain
/
loss
1,778‌
4,450‌
Increase
(decrease)
in
net
assets
from
operations
(
22‌
)
3,587‌
Distributions
to
shareholders
Net
earnings
Investor
Class
(
363‌
)
(
338‌
)
I
Class
(
363‌
)
(
466‌
)
Decrease
in
net
assets
from
distributions
(
726‌
)
(
804‌
)
Capital
share
transactions
*
Shares
sold
Investor
Class
10,769‌
25,257‌
I
Class
4,413‌
9,240‌
Distributions
reinvested
Investor
Class
351‌
323‌
I
Class
339‌
427‌
Shares
redeemed
Investor
Class
(
16,118‌
)
(
15,327‌
)
I
Class
(
6,189‌
)
(
10,002‌
)
Increase
(decrease)
in
net
assets
from
capital
share
transactions
(
6,435‌
)
9,918‌
Net
Assets
Increase
(decrease)
during
period
(
7,183‌
)
12,701‌
Beginning
of
period
48,843‌
36,142‌
End
of
period
$
41,660‌
$
48,843‌
*Share
information
(000s)
Shares
sold
Investor
Class
965‌
2,269‌
I
Class
396‌
860‌
Distributions
reinvested
Investor
Class
33‌
34‌
I
Class
33‌
46‌
Shares
redeemed
Investor
Class
(
1,497‌
)
(
1,456‌
)
I
Class
(
577‌
)
(
987‌
)
Increase
(decrease)
in
shares
outstanding
(
647‌
)
766‌
T.
ROWE
PRICE
China
Evolution
Equity
Fund
Unaudited
NOTES
TO
FINANCIAL
STATEMENTS
14
T.
Rowe
Price
International
Funds,
Inc. (the
corporation)
is
registered
under
the
Investment
Company
Act
of
1940
(the
1940
Act).
The
China
Evolution
Equity
Fund
(the
fund)
is a
diversified, open-end
management
investment
company
established
by
the
corporation. The
fund
seeks long-term
growth
of
capital.
The
fund
has two classes
of
shares:
the
China
Evolution
Equity
Fund
(Investor
Class)
and
the
China
Evolution
Equity
Fund–I
Class
(I
Class).
I
Class
shares
require
a
$500,000
initial
investment
minimum,
although
the
minimum
generally
is
waived
or
reduced
for
financial
intermediaries,
eligible
retirement
plans,
and
certain
other
accounts. Each
class
has
exclusive
voting
rights
on
matters
related
solely
to
that
class;
separate
voting
rights
on
matters
that
relate
to
both
classes;
and,
in
all
other
respects,
the
same
rights
and
obligations
as
the
other
class. 
NOTE
1
-
SIGNIFICANT
ACCOUNTING
POLICIES 
Basis
of
Preparation
 The fund
is
an
investment
company
and
follows
accounting
and
reporting
guidance
in
the
Financial
Accounting
Standards
Board
(FASB)
Accounting
Standards
Codification
Topic
946
(ASC
946).
The
accompanying
financial
statements
were
prepared
in
accordance
with
accounting
principles
generally
accepted
in
the
United
States
of
America
(GAAP),
including,
but
not
limited
to,
ASC
946.
GAAP
requires
the
use
of
estimates
made
by
management.
Management
believes
that
estimates
and
valuations
are
appropriate;
however,
actual
results
may
differ
from
those
estimates,
and
the
valuations
reflected
in
the
accompanying
financial
statements
may
differ
from
the
value
ultimately
realized
upon
sale
or
maturity.
Investment
Transactions,
Investment
Income,
and
Distributions
 Investment
transactions
are
accounted
for
on
the
trade
date
basis.
Income
and
expenses
are
recorded
on
the
accrual
basis.
Realized
gains
and
losses
are
reported
on
the
identified
cost
basis. Income
tax-related
interest
and
penalties,
if
incurred,
are
recorded
as
income
tax
expense. Dividends
received
from other
investment
companies are
reflected
as
dividend income;
capital
gain
distributions
are
reflected
as
realized
gain/loss. Dividend
income and
capital
gain
distributions
are
recorded
on
the
ex-dividend
date. Non-cash
dividends,
if
any,
are
recorded
at
the
fair
market
value
of
the
asset
received. Proceeds
from
litigation
payments,
if
any,
are
included
in
either
net
realized
gain
(loss)
or
change
in
net
unrealized
gain/loss
from
securities. Distributions
to
shareholders
are
recorded
T.
ROWE
PRICE
China
Evolution
Equity
Fund
15
on
the
ex-dividend
date. Income
distributions,
if
any,
are
declared
and
paid
by
each
class annually. A
capital
gain
distribution,
if
any, may
also
be
declared
and
paid
by
the
fund
annually.
Currency
Translation
 Assets,
including
investments,
and
liabilities
denominated
in
foreign
currencies
are
translated
into
U.S.
dollar
values
each
day
at
the
prevailing
exchange
rate,
using
the
mean
of
the
bid
and
asked
prices
of
such
currencies
against
U.S.
dollars
as
provided
by
an
outside
pricing
service.
Purchases
and
sales
of
securities,
income,
and
expenses
are
translated
into
U.S.
dollars
at
the
prevailing
exchange
rate
on
the
respective
date
of
such
transaction.
The
effect
of
changes
in
foreign
currency
exchange
rates
on
realized
and
unrealized
security
gains
and
losses
is
not
bifurcated
from
the
portion
attributable
to
changes
in
market
prices.
Class
Accounting
 Shareholder
servicing,
prospectus,
and
shareholder
report
expenses
incurred
by
each
class
are
charged
directly
to
the
class
to
which
they
relate.
Expenses
common
to
all
classes,
investment
income,
and
realized
and
unrealized
gains
and
losses
are
allocated
to
the
classes
based
upon
the
relative
daily
net
assets
of
each
class.
Capital
Transactions
 Each
investor’s
interest
in
the
net
assets
of the
fund
is
represented
by
fund
shares. The
fund’s
net
asset
value
(NAV)
per
share
is
computed
at
the
close
of
the
New
York
Stock
Exchange
(NYSE),
normally
4
p.m.
Eastern
time,
each
day
the
NYSE
is
open
for
business.
However,
the
NAV
per
share
may
be
calculated
at
a
time
other
than
the
normal
close
of
the
NYSE
if
trading
on
the
NYSE
is
restricted,
if
the
NYSE
closes
earlier,
or
as
may
be
permitted
by
the
SEC.
Purchases
and
redemptions
of
fund
shares
are
transacted
at
the
next-computed
NAV
per
share,
after
receipt
of
the
transaction
order
by
T.
Rowe
Price
Associates,
Inc.,
or
its
agents.
New
Accounting
Guidance
 In December
2023,
the
FASB
issued
Accounting
Standards
Update
(ASU),
ASU
2023-09,
Income
Taxes
(Topic
740)
–
Improvements
to
Income
Taxes
Disclosures,
which
enhances
the
transparency
of
income
tax
disclosures.
The
ASU
requires
public
entities,
on
an
annual
basis,
to
provide
disclosure
of
specific
categories
in
the
rate
reconciliation,
as
well
as
disclosure
of
income
taxes
paid
disaggregated
by
jurisdiction.
The
amendments
under
this
ASU
are
required
to
be
applied
prospectively
and
are
effective
for
fiscal
years
beginning
after
December
15,
2024.
Management
expects
that
adoption
of
the
guidance
will
not
have
a
material
impact
on
the
fund’s
financial
statements.
T.
ROWE
PRICE
China
Evolution
Equity
Fund
16
Indemnification
 In
the
normal
course
of
business, the
fund
may
provide
indemnification
in
connection
with
its
officers
and
directors,
service
providers,
and/or
private
company
investments. The
fund’s
maximum
exposure
under
these
arrangements
is
unknown;
however,
the
risk
of
material
loss
is
currently
considered
to
be
remote.
NOTE
2
-
VALUATION 
Fair
Value
  The
fund’s
financial
instruments
are
valued
at
the
close
of
the
NYSE
and
are
reported
at
fair
value,
which
GAAP
defines
as
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
at
the
measurement
date. The fund’s
Board
of
Directors
(the
Board)
has
designated
T.
Rowe
Price
Associates,
Inc.
as
the
fund’s
valuation
designee
(Valuation
Designee).
Subject
to
oversight
by
the
Board,
the
Valuation
Designee
performs
the
following
functions
in
performing
fair
value
determinations:
assesses
and
manages
valuation
risks;
establishes
and
applies
fair
value
methodologies;
tests
fair
value
methodologies;
and
evaluates
pricing
vendors
and
pricing
agents.
The
duties
and
responsibilities
of
the
Valuation
Designee
are
performed
by
its
Valuation
Committee. The
Valuation
Designee provides
periodic
reporting
to
the
Board
on
valuation
matters.
Various
valuation
techniques
and
inputs
are
used
to
determine
the
fair
value
of
financial
instruments.
GAAP
establishes
the
following
fair
value
hierarchy
that
categorizes
the
inputs
used
to
measure
fair
value:
Level
1
–
quoted
prices
(unadjusted)
in
active
markets
for
identical
financial
instruments
that
the
fund
can
access
at
the
reporting
date
Level
2
–
inputs
other
than
Level
1
quoted
prices
that
are
observable,
either
directly
or
indirectly
(including,
but
not
limited
to,
quoted
prices
for
similar
financial
instruments
in
active
markets,
quoted
prices
for
identical
or
similar
financial
instruments
in
inactive
markets,
interest
rates
and
yield
curves,
implied
volatilities,
and
credit
spreads)
Level
3
–
unobservable
inputs
(including
the Valuation
Designee’s assumptions
in
determining
fair
value)
Observable
inputs
are
developed
using
market
data,
such
as
publicly
available
information
about
actual
events
or
transactions,
and
reflect
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
Unobservable
inputs
are
those
for
which
market
data
are
not
available
and
are
developed
T.
ROWE
PRICE
China
Evolution
Equity
Fund
17
using
the
best
information
available
about
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
GAAP
requires
valuation
techniques
to
maximize
the
use
of
relevant
observable
inputs
and
minimize
the
use
of
unobservable
inputs.
When
multiple
inputs
are
used
to
derive
fair
value,
the
financial
instrument
is
assigned
to
the
level
within
the
fair
value
hierarchy
based
on
the
lowest-level
input
that
is
significant
to
the
fair
value
of
the
financial
instrument.
Input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level
but
rather
the
degree
of
judgment
used
in
determining
those
values.
Valuation
Techniques 
Equity
securities,
including
exchange-traded
funds, listed
or
regularly
traded
on
a
securities
exchange
or
in
the
over-the-
counter
(OTC)
market
are
valued
at
the
last
quoted
sale
price
or,
for
certain
markets,
the
official
closing
price
at
the
time
the
valuations
are
made.
OTC
Bulletin
Board
securities
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices.
A
security
that
is
listed
or
traded
on
more
than
one
exchange
is
valued
at
the
quotation
on
the
exchange
determined
to
be
the
primary
market
for
such
security.
Listed
securities
not
traded
on
a
particular
day
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices
for
domestic
securities
and
the
last
quoted
sale
or
closing
price
for
international
securities.
The
last
quoted
prices
of
non-U.S.
equity
securities
may
be
adjusted
to
reflect
the
fair
value
of
such
securities
at
the
close
of
the
NYSE,
if
the Valuation
Designee
determines
that
developments
between
the
close
of
a
foreign
market
and
the
close
of
the
NYSE
will
affect
the
value
of
some
or
all
of
the
fund’s portfolio
securities.
Each
business
day,
the
Valuation
Designee uses
information
from
outside
pricing
services
to
evaluate
the
quoted
prices
of
portfolio
securities
and,
if
appropriate,
decide whether
it
is
necessary
to
adjust
quoted
prices
to
reflect
fair
value
by
reviewing
a
variety
of
factors,
including
developments
in
foreign
markets,
the
performance
of
U.S.
securities
markets,
and
the
performance
of
instruments
trading
in
U.S.
markets
that
represent
foreign
securities
and
baskets
of
foreign
securities. The Valuation
Designee
uses
outside
pricing
services
to
provide
it
with
quoted
prices
and
information
to
evaluate
or
adjust
those
prices.
The Valuation
Designee
cannot
predict
how
often
it
will
use
quoted
prices
and
how
often
it
will
determine
it
necessary
to
adjust
those
prices
to
reflect
fair
value.
Investments
in
mutual
funds
are
valued
at
the
mutual
fund’s
closing
NAV
per
share
on
the
day
of
valuation.
Assets
and
liabilities
other
than
financial
instruments,
including
short-term
receivables
and
payables,
are
carried
at
cost,
or
estimated
realizable
value,
if
less,
which
approximates
fair
value. 
T.
ROWE
PRICE
China
Evolution
Equity
Fund
18
Investments
for
which
market
quotations are
not
readily
available
or
deemed
unreliable
are
valued
at
fair
value
as
determined
in
good
faith
by
the
Valuation
Designee.
The
Valuation
Designee
has
adopted
methodologies
for
determining
the
fair
value
of
investments
for
which
market
quotations
are
not
readily
available
or
deemed
unreliable,
including
the
use
of
other
pricing
sources.
Factors
used
in
determining
fair
value
vary
by
type
of
investment
and
may
include
market
or
investment
specific
considerations.
The
Valuation
Designee typically
will
afford
greatest
weight
to
actual
prices
in
arm’s
length
transactions,
to
the
extent
they
represent
orderly
transactions
between
market
participants,
transaction
information
can
be
reliably
obtained,
and
prices
are
deemed
representative
of
fair
value.
However,
the
Valuation
Designee may
also
consider
other
valuation
methods
such
as
market-based
valuation
multiples;
a
discount
or
premium
from
market
value
of
a
similar,
freely
traded
security
of
the
same
issuer;
discounted
cash
flows;
yield
to
maturity;
or
some
combination.
Fair
value
determinations
are
reviewed
on
a
regular
basis.
Because
any
fair
value
determination
involves
a
significant
amount
of
judgment,
there
is
a
degree
of
subjectivity
inherent
in
such
pricing
decisions. Fair
value
prices
determined
by
the
Valuation
Designee could
differ
from
those
of
other
market
participants,
and
it
is
possible
that
the
fair
value
determined
for
a
security
may
be
materially
different
from
the
value
that
could
be
realized
upon
the
sale
of
that
security.
Valuation
Inputs
  The
following
table
summarizes
the
fund’s
financial
instruments,
based
on
the
inputs
used
to
determine
their
fair
values
on
April
30,
2025
(for
further
detail
by
category,
please
refer
to
the
accompanying
Portfolio
of
Investments):
($000s)
Level
1
Level
2
Level
3
Total
Value
Assets
Common
Stocks
$
3,939‌
$
36,226‌
$
—‌
$
40,165‌
Short-Term
Investments
1,639‌
—‌
—‌
1,639‌
Securities
Lending
Collateral
192‌
—‌
—‌
192‌
Total
$
5,770‌
$
36,226‌
$
—‌
$
41,996‌
T.
ROWE
PRICE
China
Evolution
Equity
Fund
19
NOTE
3
-
OTHER
INVESTMENT
TRANSACTIONS 
Consistent
with
its
investment
objective, the
fund
engages
in
the
following
practices
to
manage
exposure
to
certain
risks
and/or
to
enhance
performance.
The
investment
objective,
policies,
program,
and
risk
factors
of the
fund
are
described
more
fully
in the
fund’s prospectus
and
Statement
of
Additional
Information.
Emerging
and
Frontier
Markets
 The fund
invests,
either
directly
or
through
investments
in
other
T.
Rowe
Price
funds,
in
securities
of
companies
located
in,
issued
by
governments
of,
or
denominated
in
or
linked
to
the
currencies
of
emerging
and
frontier
market
countries.
Emerging
markets,
and
to
a
greater
extent
frontier
markets, tend
to
have
economic
structures
that
are
less
diverse
and
mature,
less
developed
legal
and
regulatory
regimes,
and
political
systems
that
are
less
stable,
than
those
of
developed
countries.
These
markets
may
be
subject
to
greater
political,
economic,
and
social
uncertainty
and
differing
accounting
standards
and
regulatory
environments
that
may
potentially
impact
the
fund’s
ability
to
buy
or
sell
certain
securities
or
repatriate
proceeds
to
U.S.
dollars.
Emerging
markets
securities
exchanges
are
more
likely
to
experience
delays
with
the
clearing
and
settling
of
trades,
as
well
as
the
custody
of
holdings
by
local
banks,
agents,
and
depositories.
Such
securities
are
often
subject
to
greater
price
volatility,
less
liquidity,
and
higher
rates
of
inflation
than
U.S.
securities.
Investing
in
frontier
markets
is
typically
significantly
riskier
than
investing
in
other
countries,
including
emerging
markets.
China
A
Shares
 The
fund
invests
in
certain
Chinese
equity
securities
(A
shares)
that
have
limited
availability
to
investors
outside
of
China.
The
fund
gains
access
to
the
A
share
market
through
the
Shanghai-Hong
Kong
Stock
Connect
program
(Shanghai
Stock
Connect),
through
the
Shenzhen-Hong
Kong
Stock
Connect
program
(Shenzhen
Stock
Connect),
or
through
a
wholly
owned
subsidiary
of T.
Rowe Price
Associates,
Inc., which
serves
as
the
registered
Qualified
Foreign
Institutional
Investor
(QFII)
for
all
participating
T.
Rowe
Price-sponsored
products
(each
a
participating
account).
Related
to
A
shares
held
through
the
QFII,
investment
decisions
are
specific
to
each
participating
account,
and
each
account
bears
the
economic
consequences
of
its
holdings
and
transactions
in
A
shares.
Further,
the
fund’s
ability
to
repatriate
cash
associated
with
its
A
shares
held
through
the
QFII
is
subject
to
certain
restrictions
and
administrative
processes
involving
the
Chinese
government;
consequently,
the
fund
may
experience
substantial
delays
in
gaining
access
to
its
assets
or
incur
a
loss
of
value
in
the
event
of
noncompliance
with
governmental
requirements.
A
shares
acquired
through
the
QFII
are
valued
T.
ROWE
PRICE
China
Evolution
Equity
Fund
20
using
the
onshore
renminbi
exchange
rate
(CNY),
and
those
acquired
through
the
Shanghai
Stock
Connect
and
the
Shenzhen
Stock
Connect
are
valued
using
the
offshore
renminbi
exchange
rate
(CNH).
CNY
and
CNH
exchange
rates
may
differ;
accordingly,
A
shares
of
the
same
issue
purchased
through
different
channels
may
not
have
the
same
U.S.
dollar
value.
Generally,
the
fund
is
not
subject
to
capital
gains
tax
in
China
related
to
its
A
share
investments
through
the
QFII
(pursuant
to
a
temporary
exemption
from
tax
on
gains
derived
from
the
sale
or
disposition
of
equity
investments,
including
A
shares,
via
a
QFII).
Securities
Lending
 The fund
may
lend
its
securities
to
approved
borrowers
to
earn
additional
income.
Its
securities
lending
activities
are
administered
by
a
lending
agent
in
accordance
with
a
securities
lending
agreement.
Security
loans
generally
do
not
have
stated
maturity
dates,
and
the
fund
may
recall
a
security
at
any
time.
The
fund
receives
collateral
in
the
form
of
cash
or
U.S.
government
securities.
Collateral
is
maintained
over
the
life
of
the
loan
in
an
amount
not
less
than
the
value
of
loaned
securities;
any
additional
collateral
required
due
to
changes
in
security
values
is
delivered
to
the
fund
the
next
business
day.
Cash
collateral
is
invested
in
accordance
with
investment
guidelines
approved
by
fund
management.
Additionally,
the
lending
agent
indemnifies
the
fund
against
losses
resulting
from
borrower
default.
Although
risk
is
mitigated
by
the
collateral
and
indemnification,
the
fund
could
experience
a
delay
in
recovering
its
securities
and
a
possible
loss
of
income
or
value
if
the
borrower
fails
to
return
the
securities,
collateral
investments
decline
in
value,
and
the
lending
agent
fails
to
perform.
Securities
lending
revenue
consists
of
earnings
on
invested
collateral
and
borrowing
fees,
net
of
any
rebates
to
the
borrower,
compensation
to
the
lending
agent,
and
other
administrative
costs.
In
accordance
with
GAAP,
investments
made
with
cash
collateral
are
reflected
in
the
accompanying
financial
statements,
but
collateral
received
in
the
form
of
securities
is
not.
At
April
30,
2025,
the
value
of
loaned
securities
was
$182,000;
the
value
of
cash
collateral
and
related
investments
was
$192,000.
Other 
Purchases
and
sales
of
portfolio
securities
other
than
in-kind
transactions,
if
any,
and short-term securities
aggregated $26,679,000 and
$33,693,000,
respectively,
for
the
six
months ended
April
30,
2025. 
T.
ROWE
PRICE
China
Evolution
Equity
Fund
21
NOTE
4
-
FEDERAL
INCOME
TAXES
Generally,
no
provision
for
federal
income
taxes
is
required
since
the
fund
intends
to continue
to
qualify
as
a
regulated
investment
company
under
Subchapter
M
of
the
Internal
Revenue
Code
and
distribute
to
shareholders
all
of
its taxable
income
and
gains.
Distributions
determined
in
accordance
with
federal
income
tax
regulations
may
differ
in
amount
or
character
from
net
investment
income
and
realized
gains
for
financial
reporting
purposes.
Financial
reporting
records
are
adjusted
for
permanent
book/tax
differences
to
reflect
tax
character
but
are
not
adjusted
for
temporary
differences.
The
amount
and
character
of
tax-basis
distributions
and
composition
of
net
assets
are
finalized
at
fiscal
year-end;
accordingly,
tax-basis
balances
have
not
been
determined
as
of
the
date
of
this
report. 
The
fund
intends
to
retain
realized
gains
to
the
extent
of
available
capital
loss
carryforwards.
Net
realized
capital
losses
may
be
carried
forward
indefinitely
to
offset
future
realized
capital
gains.
As
of
October
31,
2024,
the
fund
had
$22,712,000
of
available
capital
loss
carryforwards.
At
April
30,
2025,
the
cost
of
investments
(including
derivatives,
if
any)
for
federal
income
tax
purposes
was
$41,007,000.
Net
unrealized
gain
aggregated
$990,000
at
period-end,
of
which
$4,655,000
related
to
appreciated
investments
and
$3,665,000
related
to
depreciated
investments.
NOTE
5
-
FOREIGN TAXES
The
fund
is
subject
to
foreign
income
taxes
imposed
by
certain
countries
in
which
it
invests.
Additionally,
capital
gains
realized
upon
disposition
of
securities
issued
in
or
by
certain
foreign
countries
are
subject
to
capital
gains
tax
imposed
by
those
countries.
All
taxes
are
computed
in
accordance
with
the
applicable
foreign
tax
law,
and,
to
the
extent
permitted,
capital
losses
are
used
to
offset
capital
gains.
Taxes
attributable
to
income
are
accrued
by
the
fund
as
a
reduction
of
income.
Current
and
deferred
tax
expense
attributable
to
capital
gains
is
reflected
as
a
component
of
realized
or
change
in
unrealized
gain/
loss
on
securities
in
the
accompanying
financial
statements.
To
the
extent
that
the
fund
has
country
specific
capital
loss
carryforwards,
such
carryforwards
are
applied
against
net
unrealized
gains
when
determining
the
deferred
tax
liability.
Any
deferred
tax
liability
incurred
by
the
fund
is
included
in
either
Other
liabilities
or
Deferred
tax
liability
on
the
accompanying
Statement
of
Assets
and
Liabilities.
T.
ROWE
PRICE
China
Evolution
Equity
Fund
22
NOTE
6
-
RELATED
PARTY
TRANSACTIONS
The
fund
is
managed
by
T.
Rowe
Price
Associates,
Inc.
(Price
Associates),
a
wholly
owned
subsidiary
of
T.
Rowe
Price
Group,
Inc.
(Price
Group). Price
Associates
has
entered
into
a
sub-advisory
agreement(s)
with
one
or
more
of
its
wholly
owned
subsidiaries,
to
provide
investment
advisory
services
to
the
fund.
The
investment
management
agreement
between
the
fund
and
Price
Associates
provides
for
an
annual
investment
management
fee,
which
is
computed
daily
and
paid
monthly. The
fee
consists
of
an
individual
fund
fee,
equal
to
0.70%
of
the
fund’s
average
daily
net
assets,
and
a
group
fee.
The
group
fee
rate
is
calculated
based
on
the
combined
net
assets
of
certain
mutual
funds
sponsored
by
Price
Associates
(the
group)
applied
to
a
graduated
fee
schedule,
with
rates
ranging
from
0.48%
for
the
first
$1
billion
of
assets
to
0.260%
for
assets
in
excess
of
$845
billion.
The
fund’s
group
fee
is
determined
by
applying
the
group
fee
rate
to
the
fund’s
average
daily
net
assets. At
April
30,
2025,
the
effective
annual
group
fee
rate
was
0.28%.
The
Investor
Class
is
subject
to
a
contractual
expense
limitation
through
the
expense
limitation
date
indicated
in
the
table
below.
This
agreement
will
continue
through
the
expense
limitation
date
indicated
in
the
table
below,
and
may
be
renewed,
revised,
or
revoked
only
with
approval
of
the
fund’s
Board.
During
the
limitation
period,
Price
Associates
is required
to
waive
or
pay
any
expenses
(excluding
interest;
expenses
related
to
borrowings,
taxes,
and
brokerage;
non-recurring,
extraordinary
expenses;
and
acquired
fund
fees
and
expenses)
that
would
otherwise
cause
the class’s ratio
of
annualized
total
expenses
to
average
net
assets
(net
expense
ratio)
to
exceed
its
expense
limitation.
The
class
is
required
to
repay
Price
Associates
for
expenses
previously
waived/paid
to
the
extent
the
class’s net
assets
grow
or
expenses
decline
sufficiently
to
allow
repayment
without
causing
the class’s net
expense
ratio
(after
the
repayment
is
taken
into
account)
to
exceed
the
lesser
of:
(1)
the
expense
limitation
in
place
at
the
time
such
amounts
were
waived;
or
(2)
the class’s
current
expense
limitation.
However,
no
repayment
will
be
made
more
than
three
years
after
the
date
of
a
payment
or
waiver.
The
I
Class
is
also
subject
to
an
operating
expense
limitation
(I
Class
Limit)
pursuant
to
which
Price
Associates
is
contractually
required
to
pay
all
operating
expenses
of
the
I
Class,
excluding
management
fees;
interest;
expenses
related
to
borrowings,
taxes,
and
brokerage; non-recurring,
extraordinary expenses; and
acquired
fund
fees
and
expenses, to
the
extent
such
operating
expenses,
on
an
annualized
basis,
exceed
the
I
Class
Limit. This
agreement
will
continue
through
the
expense
limitation
date
indicated
in
the
table
below,
and
may
T.
ROWE
PRICE
China
Evolution
Equity
Fund
23
be
renewed,
revised,
or
revoked
only
with
approval
of
the
fund’s
Board.
The
I
Class
is
required
to
repay
Price
Associates
for
expenses
previously
paid
to
the
extent
the
class’s
net
assets
grow
or
expenses
decline
sufficiently
to
allow
repayment
without
causing
the
class’s
operating
expenses
(after
the
repayment
is
taken
into
account)
to
exceed
the
lesser
of:
(1)
the
I
Class
Limit
in
place
at
the
time
such
amounts
were
paid;
or
(2)
the
current
I
Class
Limit.
However,
no
repayment
will
be
made
more
than
three
years
after
the
date
of
a
payment
or
waiver. 
Pursuant
to
these
agreements,
expenses
were waived/paid
by
and/or
repaid
to
Price
Associates
during
the six
months
ended April
30,
2025 as
indicated
in
the
table
below.
Including
these
amounts,
expenses
previously
waived/
paid
by
Price
Associates
in
the
amount
of $1,100,000 remain
subject
to
repayment
by
the
fund
at
April
30,
2025. Any
repayment
of
expenses
previously
waived/paid
by
Price
Associates
during
the
period
would
be
included
in
the
net
investment
income
and
expense
ratios
presented
on
the
accompanying
Financial
Highlights.
In
addition,
the
fund
has
entered
into
service
agreements
with
Price
Associates
and
a
wholly
owned
subsidiary
of
Price
Associates,
each
an
affiliate
of
the
fund
(collectively,
Price).
Price
Associates
provides
certain
accounting
and
administrative
services
to
the
fund.
T.
Rowe
Price
Services,
Inc.
provides
shareholder
and
administrative
services
in
its
capacity
as
the
fund’s
transfer
and
dividend-disbursing
agent.
For
the
six
months
ended
April
30,
2025,
expenses
incurred
pursuant
to
these
service
agreements
were
$59,000
for
Price
Associates
and
$36,000
for
T.
Rowe
Price
Services,
Inc.
All
amounts
due
to
and
due
from
Price,
exclusive
of
investment
management
fees
payable,
are
presented
net
on
the
accompanying
Statement
of
Assets
and
Liabilities.
T.
Rowe
Price
Investment
Services,
Inc.
(Investment
Services)
serves
as
distributor
to
the
fund.
Pursuant
to
an
underwriting
agreement,
no
compensation
for
any
distribution
services
provided
is
paid
to
Investment
Services
by
the
fund
(except
for
12b-1
fees
under
a
Board-approved
Rule
12b-1
plan).
Investor
Class
I
Class
Expense
limitation/I
Class
Limit
1.40%
0.05%
Expense
limitation
date
12/31/27
12/31/27
(Waived)/repaid
during
the
period
($000s)
$(83)
$(70)
T.
ROWE
PRICE
China
Evolution
Equity
Fund
24
The fund
may
invest
its
cash
reserves
in
certain
open-end
management
investment
companies
managed
by
Price
Associates
and
considered
affiliates
of
the
fund:
the
T.
Rowe
Price
Government
Reserve
Fund
or
the
T.
Rowe
Price
Treasury
Reserve
Fund,
organized
as
money
market
funds
(together,
the
Price
Reserve
Funds).
The
Price
Reserve
Funds
are
offered
as
short-term
investment
options
to
mutual
funds,
trusts,
and
other
accounts
managed
by
Price
Associates
or
its
affiliates
and
are
not
available
for
direct
purchase
by
members
of
the
public.
Cash
collateral
from
securities
lending,
if
any,
is
invested
in
the
T.
Rowe
Price
Government
Reserve Fund. The
Price
Reserve
Funds
pay
no
investment
management
fees.
As
of
April
30,
2025,
T.
Rowe
Price
Group,
Inc.,
or
its
wholly
owned
subsidiaries,
owned
596,993
shares
of
the
I
Class,
representing
33%
of
the
I
Class's
net
assets. 
The fund may
participate
in
securities
purchase
and
sale
transactions
with
other
funds
or
accounts
advised
by
Price
Associates
(cross
trades),
in
accordance
with
procedures
adopted
by the
fund’s
Board
and
Securities
and
Exchange
Commission
rules,
which
require,
among
other
things,
that
such
purchase
and
sale
cross
trades
be
effected
at
the
independent
current
market
price
of
the
security.
During
the
six
months
ended
April
30,
2025,
the
fund
had
no
purchases
or
sales
cross
trades
with
other
funds
or
accounts
advised
by
Price
Associates.
NOTE
7
-
SEGMENT
REPORTING
Operating segments
are
defined
as
components
of
a
company
that
engage
in
business
activities
and
for
which
discrete
financial
information
is
available
and
regularly
reviewed
by
the
chief
operating
decision
maker
(CODM)
in
deciding
how
to
allocate
resources
and
assess
performance.
The
Management
Committee
of
Price
Associates
acts
as
the
fund’s
CODM.
The
fund
makes
investments
in
accordance
with
its
investment
objective
as
outlined
in
the
Prospectus
and
is
considered
one
reportable
segment
because
the
CODM
allocates
resources
and
assesses
the
operating
results
of
the
fund
on
the
whole.
The
fund’s
revenue
is
derived
from
investments
in
a
portfolio
of
securities.
The
CODM
allocates
resources
and
assesses
performance
based
on
the
operating
results
of
the
fund,
which
is
consistent
with
the
results
presented
in
the
statement
of
operations,
statement
of
changes
in
net
assets
and
financial
highlights.
The
CODM
compares
the
fund’s
performance
to
its
benchmark
index
T.
ROWE
PRICE
China
Evolution
Equity
Fund
25
and
evaluates
the
positioning
of
the
fund
in
relation
to
its
investment
objective.
The
measure
of
segment
assets
is
net
assets
of
the
fund
which
is
disclosed
in
the
statement
of
assets
and
liabilities.
The accounting
policies
of
the
segment
are
the
same
as
those
described
in
the
summary
of
significant
accounting
policies.
The
financial
statements
include
all
details
of
the
segment
assets,
segment
revenue
and
expenses;
and
reflect
the
financial
results
of
the
segment.
NOTE
8
-
OTHER
MATTERS
Unpredictable environmental,
political,
social
and
economic
events,
including
but
not
limited
to,
environmental
or
natural
disasters,
war
and
conflict
(including
Russia’s
military
invasion
of
Ukraine
and
the
conflict
in
Israel,
Gaza
and
surrounding
areas),
terrorism,
geopolitical
developments
(including
trading
and
tariff
arrangements,
sanctions
and
cybersecurity
attacks),
and
public
health
epidemics
(including
the
global
outbreak
of
COVID-19)
and
similar
public
health
threats,
may
significantly
affect
the
economy
and
the
markets
and
issuers
in
which
a
fund
invests.
The
extent
and
duration
of
such
events
and
resulting
market
disruptions
cannot
be
predicted.
These
and
other
similar
events
may
cause
instability
across
global
markets,
including
reduced
liquidity
and
disruptions
in
trading
markets,
while
some
events
may
affect
certain
geographic
regions,
countries,
sectors,
and
industries
more
significantly
than
others,
and
exacerbate
other
pre-existing
political,
social,
and
economic
risks.
The
fund’s
performance
could
be
negatively
impacted
if
the
value
of
a
portfolio
holding
were
harmed
by
these
or
such
events.
Management
actively
monitors
the
risks
and
financial
impacts
arising
from
such
events.
T.
ROWE
PRICE
China
Evolution
Equity
Fund
26
APPROVAL
OF
INVESTMENT
MANAGEMENT
AGREEMENT
AND
SUBADVISORY
AGREEMENT
Each
year,
the
fund’s
Board
of
Directors
(Board)
considers
the
continuation
of
the
investment
management
agreement
(Advisory
Contract)
between
the
fund
and
its
investment
adviser,
T.
Rowe
Price
Associates,
Inc.
(Adviser),
as
well
as
the
investment
subadvisory
agreement
(Subadvisory
Contract)
that
the
Adviser
has
entered
into
with
T.
Rowe
Hong
Kong
Limited
(Subadviser)
on
behalf
of
the
fund.
In
that
regard,
at
a
meeting
held
on
March
12–13,
2025
(Meeting),
the
Board,
including
all
of
the
fund’s
independent
directors
present
in
person
at
the
Meeting,
approved
the
continuation
of
the
fund’s
Advisory
Contract
and
Subadvisory
Contract.
At
the
Meeting,
the
Board
considered
the
factors
and
reached
the
conclusions
described
below
relating
to
the
selection
of
the
Adviser
and
Subadviser
and
the
approval
of
the
Advisory
Contract
and
Subadvisory
Contract.
The
independent
directors
were
assisted
in
their
evaluation
of
the
Advisory
Contract
and
Subadvisory
Contract
by
independent
legal
counsel
from
whom
they
received
separate
legal
advice
and
with
whom
they
met
separately.
In
providing
information
to
the
Board,
the
Adviser
was
guided
by
a
detailed
set
of
requests
for
information
submitted
by
independent
legal
counsel
on
behalf
of
the
independent
directors.
In
considering
and
approving
the
continuation
of
the
Advisory
Contract
and
Subadvisory
Contract,
the
Board
considered
the
information
it
believed
was
relevant,
including,
but
not
limited
to,
the
information
discussed
below.
The
Board
considered
not
only
the
specific
information
presented
in
connection
with
the
Meeting,
but
also
the
knowledge
gained
over
time
through
interaction
with
the
Adviser
and
Subadviser
about
various
topics.
The
Board
meets
regularly
and,
at
each
of
its
meetings,
covers
an
extensive
agenda
of
topics
and
materials
and
considers
factors
that
are
relevant
to
its
annual
consideration
of
the
renewal
of
the
T.
Rowe
Price
funds’
advisory
contracts,
including
performance
and
the
services
and
support
provided
to
the
funds
and
their
shareholders.
Services
Provided
by
the
Adviser
and
Subadviser
The
Board
considered
the
nature,
quality,
and
extent
of
the
services
provided
to
the
fund
by
the
Adviser
and
Subadviser.
These
services
included,
but
were
not
limited
to,
directing
the
fund’s
investments
in
accordance
with
its
investment
program
and
the
overall
management
of
the
fund’s
portfolio,
as
well
as
a
variety
of
related
activities
such
as
financial,
investment
operations,
and
administrative
services;
compliance;
maintaining
the
fund’s
records
and
registrations;
and
shareholder
communications.
The
Board
also
reviewed
the
background
and
experience
of
the
Adviser’s
and
Subadviser’s
senior
management
teams
and
investment
personnel
involved
in
the
management
of
the
fund,
as
well
as
the
Adviser’s
compliance
record.
The
Board
concluded
that
the
information
it
considered
with
respect
to
the
nature,
quality,
and
extent
of
the
services
provided
by
the
Adviser
and
Subadviser,
as
well
as
the
other
factors
considered
at
the
Meeting,
supported
the
Board’s
approval
of
the
continuation
of
the
Advisory
Contract
and
Subadvisory
Contract.
T.
ROWE
PRICE
China
Evolution
Equity
Fund
27
Investment
Performance
of
the
Fund
The
Board
took
into
account
discussions
with
the
Adviser
and
detailed
reports
that
it
regularly
receives
throughout
the
year
on
relative
and
absolute
performance
for
the
T.
Rowe
Price
funds.
In
connection
with
the
Meeting,
the
Board
reviewed
information
provided
by
the
Adviser
that
compared
the
fund’s
total
returns,
as
well
as
a
wide
variety
of
other
previously
agreed-upon
performance
measures
and
market
data,
against
relevant
benchmark
indexes
and
peer
groups
of
funds
with
similar
investment
programs
for
various
periods
through
December
31,
2024.
Additionally,
the
Board
reviewed
the
fund’s
relative
performance
information
as
of
September
30,
2024,
which
ranked
the
returns
of
the
fund’s
Investor
Class
for
various
periods
against
a
universe
of
funds
with
similar
investment
programs
selected
by
Broadridge,
an
independent
provider
of
mutual
fund
data.
In
the
course
of
its
deliberations,
the
Board
considered
performance
information
provided
throughout
the
year
and
in
connection
with
the
Advisory
Contract
review
at
the
Meeting,
as
well
as
information
provided
during
investment
review
meetings
conducted
with
portfolio
managers
and
senior
investment
personnel
during
the
course
of
the
year
regarding
the
fund’s
performance.
The
Board
also
considered
relevant
factors,
such
as
overall
market
conditions
and
trends
that
could
adversely
impact
the
fund’s
performance,
length
of
the
fund’s
performance
track
record,
and
how
closely
the
fund’s
strategies
align
with
its
benchmarks
and
peer
groups.
The
Board
concluded
that
the
information
it
considered
with
respect
to
the
fund’s
performance,
as
well
as
the
other
factors
considered
at
the
Meeting,
supported
the
Board’s
approval
of
the
continuation
of
the
Advisory
Contract.
Costs,
Benefits,
Profits,
and
Economies
of
Scale
The
Board
reviewed
detailed
information
regarding
the
revenues
received
by
the
Adviser
under
the
Advisory
Contract
and
other
direct
and
indirect
benefits
that
the
Adviser
(and
its
affiliates,
including
the
Subadviser)
may
have
realized
from
its
relationship
with
the
fund,
including
any
research
received
under
soft-dollar
arrangements
with
broker-dealers.
In
considering
soft-dollar
arrangements,
the
Board
noted
that,
effective
January
1,
2024,
the
Adviser
began
using
brokerage
commissions
in
connection
with
certain
T.
Rowe
Price
funds’
securities
transactions
to
pay
for
research
when
permissible,
and
the
Board
considered
that
the
Adviser
may
receive
some
benefit
from
soft-dollar
arrangements
pursuant
to
which
research
is
received
from
broker-dealers
that
execute
the
applicable
fund’s
portfolio
transactions.
APPROVAL
OF
INVESTMENT
MANAGEMENT
AGREEMENT
AND
SUBADVISORY
AGREEMENT
(continued)
T.
ROWE
PRICE
China
Evolution
Equity
Fund
28
The
Board
received
information
on
the
estimated
costs
incurred
and
profits
realized
by
the
Adviser
from
managing
the
T.
Rowe
Price
funds.
While
the
Board
did
not
review
information
regarding
profits
realized
from
managing
the
fund
in
particular
because
the
fund
had
either
not
achieved
sufficient
portfolio
asset
size
or
not
recognized
sufficient
revenues
to
produce
meaningful
profit
margin
percentages,
the
Board
concluded
that
the
Adviser’s
profits
were
reasonable
in
light
of
the
services
provided
to
the
T.
Rowe
Price
funds.
The
Board
also
considered
whether
the
fund
benefits
under
the
fee
levels
set
forth
in
the
Advisory
Contract
or
otherwise
from
any
economies
of
scale
realized
by
the
Adviser.
Under
the
Advisory
Contract,
the
fund
pays
a
fee
to
the
Adviser
for
investment
management
services
composed
of
two
components
–
a
group
fee
rate
based
on
the
combined
average
net
assets
of
most
of
the
T.
Rowe
Price
funds
(including
the
fund)
that
declines
at
certain
asset
levels
and
an
individual
fund
fee
rate
based
on
the
fund’s
average
daily
net
assets
–
and
the
fund
pays
its
own
expenses
of
operations.
Under
the
Subadvisory
Contract,
the
Adviser
may
pay
the
Subadviser
up
to
60%
of
the
advisory
fees
that
the
Adviser
receives
from
the
fund.
The
group
fee
schedule
is
graduated
so
the
rate
decreases
as
total
T.
Rowe
Price
fund
assets
increase
and
increases
as
total
T.
Rowe
Price
fund
assets
decrease.
As
a
result,
shareholders
benefit
from
overall
growth
in
T.
Rowe
Price
fund
assets,
which
reduces
the
management
fee
rate
for
any
fund
that
has
a
group
fee
component
to
its
management
fee,
and
reflects
that
certain
resources
utilized
to
operate
the
fund
are
shared
with
other
T.
Rowe
Price
funds
thus
allowing
shareholders
of
those
funds
to
share
potential
economies
of
scale.
The
fund’s
shareholders
also
benefit
from
potential
economies
of
scale
through
a
decline
in
certain
operating
expenses
as
the
fund
grows
in
size.
However,
the
fund
is
also
subject
to
a
contractual
expense
limitation
that
requires
the
Adviser
to
waive
its
fees
and/or
bear
any
expenses
that
would
otherwise
cause
the
expenses
of
a
share
class
of
the
fund
to
exceed
a
certain
percentage
based
on
the
class’s
net
assets.
The
expense
limitations
protect
shareholders
from
relatively
high
expenses
until
the
fund
reaches
greater
scale
and
mitigate
the
potential
for
an
increase
in
operating
expenses
above
a
certain
level
that
could
impact
shareholders.
In
addition,
the
Board
noted
that
the
fund
potentially
shares
in
indirect
economies
of
scale
through
the
Adviser’s
ongoing
investments
in
its
business
in
support
of
the
T.
Rowe
Price
funds,
including
investments
in
trading
systems,
technology,
and
regulatory
support
enhancements,
and
the
ability
to
possibly
negotiate
lower
fee
arrangements
with
third-party
service
providers.
The
Board
concluded
that
the
advisory
fee
structure
for
the
fund
provides
for
a
reasonable
sharing
of
benefits
from
any
economies
of
scale
with
the
fund’s
investors.
APPROVAL
OF
INVESTMENT
MANAGEMENT
AGREEMENT
AND
SUBADVISORY
AGREEMENT
(continued)
T.
ROWE
PRICE
China
Evolution
Equity
Fund
29
Fees
and
Expenses
The
Board
was
provided
with
information
regarding
industry
trends
in
management
fees
and
expenses.
Among
other
things,
the
Board
reviewed
data
for
peer
groups
that
were
compiled
by
Broadridge,
which
compared:
(i)
contractual
management
fees,
actual
management
fees,
nonmanagement
expenses,
and
total
expenses
of
the
Investor
Class
of
the
fund
with
a
group
of
competitor
funds
selected
by
Broadridge
(Expense
Group);
and
(ii)
actual
management
fees,
nonmanagement
expenses,
and
total
expenses
of
the
Investor
Class
of
the
fund
with
a
broader
set
of
funds
within
the
Lipper
investment
classification
(Expense
Universe).
The
Board
considered
the
fund’s
contractual
management
fee
rate,
actual
management
fee
rate
(which
reflects
the
management
fees
actually
received
from
the
fund
by
the
Adviser
after
any
applicable
waivers,
reductions,
or
reimbursements),
operating
expenses,
and
total
expenses
(which
reflect
the
net
total
expense
ratio
of
the
fund
after
any
waivers,
reductions,
or
reimbursements)
in
comparison
with
the
information
for
the
Broadridge
peer
groups.
Broadridge
generally
constructed
the
peer
groups
by
seeking
the
most
comparable
funds
based
on
similar
investment
classifications
and
objectives,
expense
structure,
asset
size,
and
operating
components
and
attributes
and
ranked
funds
into
quintiles,
with
the
first
quintile
representing
the
funds
with
the
lowest
relative
expenses
and
the
fifth
quintile
representing
the
funds
with
the
highest
relative
expenses.
The
information
provided
to
the
Board
indicated
that
the
fund’s
contractual
management
fee
ranked
in
the
third
quintile
(Expense
Group),
the
fund’s
actual
management
fee
rate
ranked
in
the
first
quintile
(Expense
Group
and
Expense
Universe),
and
the
fund’s
total
expenses
ranked
in
the
third
quintile
(Expense
Group
and
Expense
Universe).
The
Board
also
reviewed
the
fee
schedules
for
other
investment
portfolios
with
similar
mandates
that
are
advised
or
subadvised
by
the
Adviser
and
its
affiliates,
including
separately
managed
accounts
for
institutional
and
individual
investors;
subadvised
funds;
and
other
sponsored
investment
portfolios,
including
collective
investment
trusts
and
pooled
vehicles
organized
and
offered
to
investors
outside
the
United
States.
The
fee
schedules,
which
are
subject
to
change,
may
be
negotiated
under
certain
circumstances
and
may
differ
across
regions.
Management
provided
the
Board
with
information
about
the
Adviser’s
responsibilities
and
services
provided
to
subadvisory
and
other
institutional
account
clients,
including
information
about
how
the
requirements
and
economics
of
the
institutional
domestic
and
international
businesses
are
fundamentally
different
from
those
of
the
proprietary
mutual
fund
and
ETF
(“registered
fund”)
business.
The
Board
considered
information
showing
that
the
Adviser’s
registered
fund
business
is
generally
more
complex
from
a
business
and
compliance
perspective
than
its
other
domestic
and
international
businesses
and
considered
various
relevant
factors,
such
as
the
broader
scope
of
operations
and
oversight,
more
extensive
shareholder
communication
infrastructure,
greater
asset
flows,
heightened
business
risks,
APPROVAL
OF
INVESTMENT
MANAGEMENT
AGREEMENT
AND
SUBADVISORY
AGREEMENT
(continued)
T.
ROWE
PRICE
China
Evolution
Equity
Fund
30
and
differences
in
applicable
laws
and
regulations
associated
with
the
Adviser’s
proprietary
registered
fund
business.
In
assessing
the
reasonableness
of
the
fund’s
management
fee
rate,
the
Board
considered
the
differences
in
the
nature
of
the
services
required
for
the
Adviser
to
manage
its
registered
fund
business
versus
managing
a
discrete
pool
of
assets
as
a
subadviser
to
another
institution’s
mutual
fund
or
for
an
institutional
account
and
that
the
Adviser
generally
performs
significant
additional
services
and
assumes
greater
risk
in
managing
the
fund
and
other
T.
Rowe
Price
funds
than
it
does
for
institutional
account
clients,
including
subadvised
funds.
On
the
basis
of
the
information
provided
and
the
factors
considered,
the
Board
concluded
that
the
fees
paid
by
the
fund
under
the
Advisory
Contract
are
reasonable.
Approval
of
the
Advisory
Contract
and
Subadvisory
Contract
As
noted,
the
Board
approved
the
continuation
of
the
Advisory
Contract
and
Subadvisory
Contract.
No
single
factor
was
considered
in
isolation
or
to
be
determinative
to
the
decision.
Rather,
the
Board
concluded,
in
light
of
a
weighting
and
balancing
of
all
factors
considered,
that
it
was
in
the
best
interests
of
the
fund
and
its
shareholders
for
the
Board
to
approve
the
continuation
of
the
Advisory
Contract
and
Subadvisory
Contract
(including
the
fees
to
be
charged
for
services
thereunder).
APPROVAL
OF
INVESTMENT
MANAGEMENT
AGREEMENT
AND
SUBADVISORY
AGREEMENT
(continued)
1307
Point
Street
Baltimore,
Maryland
21231
T.
Rowe
Price
Investment
Services,
Inc.
Call
1-800-225-5132
to
request
a
prospectus
or
summary
prospectus;
each
includes
investment
objectives,
risks,
fees,
expenses,
and
other
information
that
you
should
read
and
consider
carefully
before
investing.
F1228-051
6/25

Item 8. Changes in and Disagreements with Accountants for Open-End Management Investment Companies.

Not applicable.

Item 9. Proxy Disclosures for Open-End Management Investment Companies.

Not applicable.

Item 10. Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies.

Remuneration paid to Directors is included in Item 7 of this Form N-CSR.

 

Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract.

If applicable, see Item 7.

Item 12. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

Not applicable.

Item 13. Portfolio Managers of Closed-End Management Investment Companies.

Not applicable.

Item 14. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.

Not applicable.

Item 15. Submission of Matters to a Vote of Security Holders.

There has been no change to the procedures by which shareholders may recommend nominees to the registrant’s board of directors.

Item 16. Controls and Procedures.

(a) The registrant’s principal executive officer and principal financial officer have evaluated the registrant’s disclosure controls and procedures within 90 days of this filing and have concluded that the registrant’s disclosure controls and procedures were effective, as of that date, in ensuring that information required to be disclosed by the registrant in this Form N-CSR was recorded, processed, summarized, and reported timely.

(b) The registrant’s principal executive officer and principal financial officer are aware of no change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

Item 17. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.

Not applicable.

Item 18. Recovery of Erroneously Awarded Compensation.

Not applicable.

Item 19. Exhibits.

 

(a)(1)    

The registrant’s code of ethics pursuant to Item 2 of Form N-CSR is filed with the registrant’s annual Form N-CSR.

    (2)    

Listing standards relating to recovery of erroneously awarded compensation: Not applicable.

    (3)    

Separate certifications by the registrant’s principal executive officer and principal financial officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 and required by Rule 30a-2(a) under the Investment Company Act of 1940, are attached.

 

(b)       

A certification by the registrant’s principal executive officer and principal financial officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and required by Rule 30a-2(b) under the Investment Company Act of 1940, is attached.

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

T. Rowe Price International Funds, Inc.
By  

/s/ David Oestreicher

      
  David Oestreicher  
  Principal Executive Officer  
Date    June 17, 2025  

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

By  

/s/ David Oestreicher

  
  David Oestreicher  
  Principal Executive Officer      
Date   

June 17, 2025

  

 

By  

/s/ Alan S. Dupski

  
  Alan S. Dupski  
  Principal Financial Officer      
Date   

June 17, 2025